| Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More | Frank Vinluan | 04/24/20 | National |
| Affinivax Lands $120M to Take MAPS Tech Into New Vaccine Territory | Frank Vinluan | 04/23/20 | Boston |
| SutroVax Lands $64M From Roche, Others to Back Vaccine Studies | Frank Vinluan | 03/21/17 | San Francisco |
| Bio Roundup: Healthcare Is Hard, “Slow” FDA, Drugging RNA & More | Alex Lash | 03/03/17 | National |
| Affinivax Obtains $2,500,000 New Funding Round | VentureDeal | 02/05/16 | Boston |
| Genocea Ditches Pneumococcus Vaccine After Phase 2 Flop, Shares Fall | Ben Fidler | 10/19/15 | Boston |
| East Coast Biotech Roundup: Genzyme, 21st Century Cures, Acorda, & More | Ben Fidler | 02/13/15 | Boston |
| Accelerate LI’s Latest Startup Aims to Rewire Viruses With Software | Ben Fidler | 12/16/14 | New York |
| East Coast Biotech Roundup: Sarepta, Aegerion, Syros, Aileron & More | Ben Fidler | 10/31/14 | Boston |
| Affinivax Garners $4,000,000 New Round | VentureDeal | 10/31/14 | Boston |
| Backed by Gates, Affinivax Ramps up Velcro-like Vaccine Tech | Ben Fidler | 10/30/14 | Boston |
